Prof. Sameh Lashen: Leading Researcher in Gastroenterology

🎉 Congratulations Prof. Sameh Lashen on Winning the Best Researcher Award! 🏆 Your dedication to research, mentorship, and collaboration with international teams is truly commendable. This award is a testament to your outstanding work and the impact it has on the broader community.

🔍 Summary: Prof. Sameh Lashen is an accomplished gastroenterologist and hepatologist with extensive expertise in internal medicine. He holds a European Specialty Examination in Gastroenterology and Hepatology and earned his Doctorate and Master’s degrees in internal medicine from the University of Alexandria, Egypt. Prof. Lashen’s research, widely cited in the medical community, focuses on diverse areas, including hepatocellular carcinoma management, colorectal cancer, post-COVID-19 syndrome, and the efficacy of antiviral drugs in hepatitis C eradication. His commitment to advancing medical knowledge is evident in his numerous publications that contribute significantly to the field.

Professional Profile:

• Scopus Profile 
• Orcid Profile
• Google Scholar

🎓 Education:

• European Specialty Examination in Gastroenterology and Hepatology [ESEGH], UK.
• Doctor degree in internal medicine, Faculty of Medicine, University of Alexandria, Egypt.
• Master’s degree in internal medicine, Faculty of Medicine, Alexandria University, Egypt.
• Bachelor’s degree (MBChB) in Medicine and Surgery, Faculty of Medicine, Alexandria University.

📚 Publications Top Noted:

1. “Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: a randomized controlled trial.” (Cited 63 times)
2. “Colorectal cancer in the Arab world: A systematic review.” (Cited 18 times)
3. “Post-COVID-19 Syndrome Clinical Manifestations: A Systematic Review.” (Cited 15 times)
4. “Tolerability and effectiveness of generic direct-acting antiviral drugs in the eradication of hepatitis C genotype 4 among Egyptian patients.” (Cited 10 times)
5. “Role of The von Willebrand Factor and The Vitro Score as Predictors for Variceal Bleeding in Patients with Hepatitis C-Related Cirrhosis.” (Cited 10 times)
6. “Efficacy of Lactoferrin with Standard Triple Therapy or Sequential Therapy for Helicobacter pylori Eradication: A Randomized Controlled Trial.” (Cited 8 times)
7. “Hepatocellular Carcinoma Occurrence/Recurrence after Direct-Acting Antivirals for Hepatitis C in Egyptian Cohort: Single-Centre Experience.” (Cited 7 times)
8. “Liver fibrosis regression after direct-acting antivirals for hepatitis C Virus: A prospective study.” (Cited 5 times)
9. “Plasma microRNA-192 expression as a potential biomarker of diabetic kidney disease in patients with type 2 diabetes mellitus.” (Cited 5 times)
10. “Barriers for resuming endoscopy service in the context of COVID-19 pandemic: A multicenter survey from Egypt.” (Cited 4 times)

🔍 Research Focus:

• Gastroenterology and Hepatology
• Hepatocellular Carcinoma
• Colorectal Cancer
• Post-COVID-19 Syndrome
• Hepatitis C Treatment
• Variceal Bleeding Predictors
• Helicobacter pylori Eradication
• Liver Fibrosis Regression
• Biomarkers for Diabetic Kidney Disease
• Endoscopy Service Resumption in COVID-19 Pandemic